AminologicsLtd Past Earnings Performance
Past criteria checks 3/6
AminologicsLtd's earnings have been declining at an average annual rate of -37.7%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 5.9% per year. AminologicsLtd's return on equity is 4.5%, and it has net margins of 11.7%.
Key information
-37.7%
Earnings growth rate
-37.7%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 5.9% |
| Return on equity | 4.5% |
| Net Margin | 11.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
AminologicsLtd's (KOSDAQ:074430) Shareholders May Want To Dig Deeper Than Statutory Profit
Mar 27
Some Investors May Be Worried About AminologicsLtd's (KOSDAQ:074430) Returns On Capital
Mar 01Returns At AminologicsLtd (KOSDAQ:074430) Are On The Way Up
May 05Should Weakness in Aminologics Co.,Ltd.'s (KOSDAQ:074430) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 19If You Had Bought AminologicsLtd (KOSDAQ:074430) Stock Five Years Ago, You Could Pocket A 137% Gain Today
Feb 04Revenue & Expenses BreakdownBeta
How AminologicsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 20,887 | 2,436 | 4,527 | 1,307 |
| 30 Sep 23 | 18,798 | -13,256 | 5,396 | 165 |
| 30 Jun 23 | 22,265 | -10,122 | 5,574 | 199 |
| 31 Mar 23 | 23,275 | -9,357 | 5,530 | 210 |
| 31 Dec 22 | 27,337 | -7,282 | 5,305 | 216 |
| 30 Sep 22 | 27,856 | 5,746 | 5,383 | 208 |
| 30 Jun 22 | 24,633 | 4,128 | 4,937 | 342 |
| 31 Mar 22 | 26,602 | 7,717 | 4,629 | 382 |
| 31 Dec 21 | 22,849 | 5,360 | 4,405 | 474 |
| 30 Sep 21 | 20,596 | 7,321 | 3,976 | 563 |
| 30 Jun 21 | 21,369 | 7,073 | 3,918 | 460 |
| 31 Mar 21 | 17,996 | 3,442 | 3,778 | 405 |
| 31 Dec 20 | 17,651 | 2,140 | 3,805 | 340 |
| 30 Sep 20 | 18,312 | -1,468 | 3,714 | 284 |
| 30 Jun 20 | 17,219 | -2,180 | 3,761 | 264 |
| 31 Mar 20 | 17,570 | -2,789 | 3,867 | 297 |
| 31 Dec 19 | 18,980 | -1,201 | 3,578 | 226 |
| 30 Sep 19 | 18,964 | 5,909 | -124 | 202 |
| 30 Jun 19 | 19,226 | 6,864 | -343 | 202 |
| 31 Mar 19 | 20,061 | 8,182 | -488 | 137 |
| 31 Dec 18 | 18,450 | 7,996 | -581 | 161 |
| 30 Sep 18 | 17,758 | 2,977 | 2,389 | 269 |
| 30 Jun 18 | 17,335 | 2,307 | 2,164 | 268 |
| 31 Mar 18 | 16,638 | 883 | 2,062 | 251 |
| 31 Dec 17 | 16,835 | 542 | 1,897 | 225 |
| 30 Sep 17 | 16,463 | -3,569 | 2,114 | 195 |
| 30 Jun 17 | 16,845 | -3,520 | 2,058 | 171 |
| 31 Mar 17 | 16,541 | -3,602 | 2,179 | 167 |
| 31 Dec 16 | 16,366 | -3,742 | 2,335 | 153 |
| 30 Sep 16 | 18,326 | 2,891 | 2,145 | 54 |
| 30 Jun 16 | 17,161 | 2,990 | 2,417 | 58 |
| 31 Mar 16 | 14,050 | -1,447 | 2,314 | 63 |
| 31 Dec 15 | 10,997 | -2,825 | 2,359 | 77 |
| 30 Sep 15 | 6,404 | -10,069 | 2,946 | 114 |
| 30 Jun 15 | 4,033 | -11,350 | 2,949 | 144 |
| 31 Mar 15 | 3,941 | -8,278 | 2,962 | 145 |
| 31 Dec 14 | 3,541 | -8,100 | 3,159 | 168 |
| 30 Sep 14 | 3,147 | -10,013 | 2,244 | 144 |
| 30 Jun 14 | 2,732 | -11,281 | 2,419 | 102 |
| 31 Mar 14 | 2,192 | -12,488 | 3,545 | 91 |
| 31 Dec 13 | 3,276 | -13,389 | 4,610 | 43 |
| 30 Sep 13 | 4,206 | -16,907 | 14,524 | 101 |
| 30 Jun 13 | 4,377 | -14,133 | 14,798 | 101 |
Quality Earnings: A074430 has high quality earnings.
Growing Profit Margin: A074430 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A074430 has become profitable over the past 5 years, growing earnings by -37.7% per year.
Accelerating Growth: A074430 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A074430 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-15.5%).
Return on Equity
High ROE: A074430's Return on Equity (4.5%) is considered low.